SCHEMBL27237483

SCHEMBL27237483

CCCOc1ccc(-c2cccc(C(=O)NN=Cc3cc(OC)cc(OC)c3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ MGAM O43451 1/20 0.49
▸ ALDH1A1 P00352 5/20 0.48
▸ HPGD P15428 4/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ POLB P06746 3/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ PAX8 Q06710 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ AR P10275 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.44
▸ PLA2G2A P14555 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30862205 1.00 KMT2A (0.56) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL25003813 1.00 KMT2A (0.56) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL27237484 0.96 KMT2A (0.56) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL25002946 0.96 KMT2A (0.56) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL25003158 0.92 KMT2A (0.58) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL27237401 0.92 KMT2A (0.58) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL25003809 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL30951025 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL27237446 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL29215006 0.89 SCN2A (0.51) KMT2AMEN1MGAMALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
Send feedback